Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06773338

The Impact of Playing Tetris on Migrants' Mental Health

Does Playing Tetris Prevent the Development of Post-Traumatic Stress Disorder or Related Anxiety and Depressive Symptoms During and After Migration?

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Tilburg University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study examines if playing Tetris prevents the development of Post-traumatic stress disorder or related anxiety and depressive symptoms. The investigators recruit 300 participants in total in Greece and in the Netherlands. The participants are immigrants who have applied for asylum at any point in the past. The participants are asked to answer three questionnaires (on Post-traumatic stress disorder, related anxiety and depressive symptoms, and post-migration living difficulties) on a recurring basis - once every 4 weeks, 12 times in total. Half of the participants (treatment group) are randomly selected to play Tetris after completing the questionnaires. Participants in the treatment group are instructed to play Tetris for at least 15 minutes while trying to remember bad things that recently happened to them. Tetris is administered at three instances and participants in the treatment group are encouraged to play Tetris in case of experiencing any traumatic events or having any intrusive memories during the course of the study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTetrisRandomly selected participants (migrants) are asked to play Tetris for at least 15 minutes on several occasions. These participants are asked while playing Tetris to try and remember bad events that recently happened to them. The participants play the classic version of the Tetris game directly on their mobile phone.
OTHERNo interventionParticipants do not receive any intervention.

Timeline

Start date
2024-12-17
Primary completion
2025-12-07
Completion
2025-12-07
First posted
2025-01-14
Last updated
2025-01-14

Locations

2 sites across 2 countries: Greece, Netherlands

Source: ClinicalTrials.gov record NCT06773338. Inclusion in this directory is not an endorsement.